Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Patches in Severe COVID-19 ICU Patients
NCT04598594Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2020
- Primary completion
- Apr 2021
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nicotine patch in coronavirus disease 2019 (COVID-19), sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2020; status: completed.
02
Drugs
nicotine patch
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04598594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04598594.